Brief: Microbot Medical Completes The Enrollment Of Clinical Sites In Its Pivotal Human Clinical Trial With The Addition Of Memorial Sloan Kettering Cancer Center
18/07/2024 13:34
July 18 (Reuters) - Microbot Medical Inc MBOT.O :
* MICROBOT MEDICAL COMPLETES THE ENROLLMENT OF CLINICAL
SITES IN
ITS PIVOTAL HUMAN CLINICAL TRIAL WITH THE ADDITION OF MEMORIAL
SLOAN KETTERING CANCER CENTER
Source text for Eikon: ID:nGNX6zF8zJ
Further company coverage: MBOT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microbot Medical
See all newsBrief: Microbot Medical® Enters Into An Agreement To Expand Access For America’S Veteran And Military Patient Populations
Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device
Brief: Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System
Brief: Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites
Brief: Microbot Medical Continues Its 2025 Momentum Announces Key 2026 Milestones